Ceramide synthases and ceramide levels are increased in breast cancer tissue.
about
Ceramide synthases at the centre of sphingolipid metabolism and biologyMammalian ceramide synthasesA critical role for ceramide synthase 2 in liver homeostasis: II. insights into molecular changes leading to hepatopathyAntiapoptotic roles of ceramide-synthase-6-generated C16-ceramide via selective regulation of the ATF6/CHOP arm of ER-stress-response pathways.Re-configuration of sphingolipid metabolism by oncogenic transformation.A New Gene Expression Signature for Triple Negative Breast Cancer Using Frozen Fresh Tissue before Neoadjuvant Chemotherapy.Mass spectrometry-based quantitative metabolomics revealed a distinct lipid profile in breast cancer patients.Interdiction of sphingolipid metabolism to improve standard cancer therapies.Selective knockdown of ceramide synthases reveals complex interregulation of sphingolipid metabolismLC/MS analysis of stratum corneum lipids: ceramide profiling and discoveryRegulation of ceramide synthase by casein kinase 2-dependent phosphorylation in Saccharomyces cerevisiaeCERS2 suppresses tumor cell invasion and is associated with decreased V-ATPase and MMP-2/MMP-9 activities in breast cancer.Alteration of ceramide synthase 6/C16-ceramide induces activating transcription factor 6-mediated endoplasmic reticulum (ER) stress and apoptosis via perturbation of cellular Ca2+ and ER/Golgi membrane network.High CerS5 expression levels associate with reduced patient survival and transition from apoptotic to autophagy signalling pathways in colorectal cancerExpression of a tumor-associated gene, LASS2, in the human bladder carcinoma cell lines BIU-87, T24, EJ and EJ-M3.A Pilot Study on the Potential of RNA-Associated to Urinary Vesicles as a Suitable Non-Invasive Source for Diagnostic Purposes in Bladder Cancer.LASS2 inhibits growth and invasion of bladder cancer by regulating ATPase activity.Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.Ceramide synthases in mammalians, worms, and insects: emerging schemes.Increased ceramide production sensitizes breast cancer cell response to chemotherapy.Interference with distinct steps of sphingolipid synthesis and signaling attenuates proliferation of U87MG glioma cells.LASS2/TMSG1 inhibits growth and invasion of breast cancer cell in vitro through regulation of vacuolar ATPase activity.LASS2 enhances chemosensitivity of breast cancer by counteracting acidic tumor microenvironment through inhibiting activity of V-ATPase proton pump.Comparative Analysis of Biological Sphingolipids with Glycerophospholipids and Diacylglycerol by LC-MS/MSAltered sphingolipid metabolism in patients with metastatic pancreatic cancer.High levels of sphingolipids in human breast cancer.Exacerbation of experimental autoimmune encephalomyelitis in ceramide synthase 6 knockout mice is associated with enhanced activation/migration of neutrophils.Acid ceramidase is associated with an improved prognosis in both DCIS and invasive breast cancer.Ceramide synthase-4 orchestrates the cell proliferation and tumor growth of liver cancer in vitro and in vivo through the nuclear factor-κB signaling pathway.Progression of pathology in PINK1-deficient mouse brain from splicing via ubiquitination, ER stress, and mitophagy changes to neuroinflammation.The role of LASS2 in regulating bladder cancer cell tumorigenicity in a nude mouse model.Comprehensive lipid profiling of plasma in patients with benign breast tumor and breast cancer reveals novel biomarkers.Sphingolipid metabolism in cancer signalling and therapy.Candidate genes involving in tumorigenesis of cholangiocarcinoma induced by Opisthorchis viverrini infection.Disruption of the ceramide synthase LOH1 causes spontaneous cell death in Arabidopsis thaliana.Myriocin, a serine palmitoyltransferase inhibitor, suppresses tumor growth in a murine melanoma model by inhibiting de novo sphingolipid synthesis.c-Src-induced activation of ceramide metabolism impairs membrane microdomains and promotes malignant progression by facilitating the translocation of c-Src to focal adhesions.Identification of N-acyl-fumonisin B1 as new cytotoxic metabolites of fumonisin mycotoxins.Identification of an acid sphingomyelinase ceramide kinase pathway in the regulation of the chemokine CCL5.Ceramide species are elevated in human breast cancer and are associated with less aggressiveness.
P2860
Q24609859-0A1F03F4-0B84-4C53-83A6-B1333FD2CE6DQ24633453-284DFAAB-EEA4-4F5C-B9B0-F204E948651FQ24634622-791308B0-D5A3-4403-9747-626AB12D9462Q33552843-4B5266FF-2B0A-41FE-93D8-D93EEECF221FQ33649823-BA3F1F43-FD83-4317-BE11-17F19A630C9AQ33793872-9E9AA74A-5F48-4C09-9A3A-B44506E3E4D9Q34339067-D882D2F0-94BD-44FA-B0C9-64E915655FB8Q34373466-7A5618A8-6025-4CD5-A1BB-6AA59953B3A7Q34395114-48F5BABF-72AB-4440-889B-9D43B3E08431Q34955959-BAEDF866-851C-4F68-8D8D-ABB9C07AD5A0Q35121224-62922FE1-5831-44E5-A847-0FAF8F647AAEQ35249007-D323BDE0-4E99-4DE1-A487-7B15A5CE3DF0Q35605031-D04D29BB-C37A-47CE-99FE-4AE7F8CBC1C2Q36097185-255E2607-021C-4133-900F-C65DE5FD86F9Q36603997-87041D97-B188-456F-948F-2912312AF570Q37693488-E20AAA08-8C9D-4771-B6BB-1D4FE5372487Q37701271-87343224-CC15-4DF7-96F4-420C6D1E2F8DQ37808219-59672DA1-730F-47C5-9EBD-C9DA73732562Q38472485-405DFF6C-2B25-4B43-BB05-B72958DEF339Q38709652-A9E85C3A-868C-4E65-8AD3-4F9DE96F5B27Q38871772-2948EA5E-ADC0-47B5-83A6-5330266879A4Q38929282-3F555E79-5DF0-44C9-A0C7-A7EF6D292C82Q39349232-28C9EDC4-9E17-4099-AF76-6E10BB60C306Q39532828-5ECE30EA-BAD6-419B-B438-975DDEFE5BD6Q39871481-1931EA61-4DBA-47E9-A2AB-CB2CB426EF45Q40964594-E84EEA20-99EE-430D-B74A-4DF1D85BC5CEQ41126508-173CA3B6-8EA0-416D-A214-4E08AF32A0C2Q41135883-2316A715-0DA4-483F-B22A-8AAA66240EFEQ41142815-E376BF02-FC61-4573-8523-1C829DCB3DB1Q41228349-8208438A-EE6A-4356-AD71-67FC2075A747Q43753226-DB235157-6ECD-401D-9188-6D0DA47CBABDQ46777565-B1B9DFEB-77FF-4E52-904F-98E70C7DFE6FQ49950035-A4F01519-BD60-46DB-9641-2C40B7728A0AQ51769275-932B7A12-0771-403F-8C09-CC1C526C2306Q52615756-8AF5D93C-6524-4415-83B7-5DEC847D3AB3Q53185416-08ABECD1-7929-4FD0-9A9A-71E69B55EAA0Q53246197-A2E92E47-5B2B-48DB-867A-13340AFF0700Q53260162-60B4D4ED-1A3C-4E93-87CB-D952EC4C16C5Q54979802-5F343188-7F86-4786-8F44-9A48F6BD418EQ55002300-49A18DC3-C6E5-44F3-A9E1-F483CF6B2192
P2860
Ceramide synthases and ceramide levels are increased in breast cancer tissue.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Ceramide synthases and ceramide levels are increased in breast cancer tissue.
@ast
Ceramide synthases and ceramide levels are increased in breast cancer tissue.
@en
Ceramide synthases and ceramide levels are increased in breast cancer tissue.
@nl
type
label
Ceramide synthases and ceramide levels are increased in breast cancer tissue.
@ast
Ceramide synthases and ceramide levels are increased in breast cancer tissue.
@en
Ceramide synthases and ceramide levels are increased in breast cancer tissue.
@nl
prefLabel
Ceramide synthases and ceramide levels are increased in breast cancer tissue.
@ast
Ceramide synthases and ceramide levels are increased in breast cancer tissue.
@en
Ceramide synthases and ceramide levels are increased in breast cancer tissue.
@nl
P2093
P356
P1433
P1476
Ceramide synthases and ceramide levels are increased in breast cancer tissue.
@en
P2093
Carlo Angioni
Eugen Ruckhäberle
Gerd Geisslinger
Hanns Ackermann
Helmut Schmidt
Ivonne Wobst
Jessica Sandner
Kerstin Birod
Manfred Kaufmann
Sabine Grösch
P304
P356
10.1093/CARCIN/BGP061
P407
P577
2009-03-11T00:00:00Z